Experimental pancreatic cancer vaccine demonstrates sustained immune response in clinical testing

An experimental vaccine has successfully induced long-lasting immune responses in high-risk individuals, marking a potential advancement in preventative oncology. The clinical significance remains subject to further longitudinal data to confirm efficacy in preventing tumor development.